Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions. 1980

J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good

Serum zinc, copper, and the Cu/Zn ratio were evaluated in 80 patients with breast lesions prior to surgery. There were 37 patients with benign and 43 with malignant breast lesions. There was no evidence of weight loss, impaired appetite, or change in eating pattern in any of the patients. There was a statistically significant difference for the mean SCL and Cu/Zn ratio between controls, age 66-94, and patients with malignant breast lesions. This difference was also observed between the ages of 20-45 and 66-94 among controls, suggesting that this is age related rather than disease related. The range of distribution for SZL and SCL were similar for all groups studied. Neither SZL, SCL, or the Cu/Zn ratio were of value in discriminating between controls and patients with benign or malignant breast lesions. We were unable to demonstrate the value of these parameters as markers of disease activity in patient with benign or malignant breast lesions.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
January 2005, Indian journal of dermatology, venereology and leprology,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
January 1980, Journal of surgical oncology,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
July 1973, Rinsho byori. The Japanese journal of clinical pathology,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
October 2003, Biological trace element research,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
September 2005, Journal of surgical oncology,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
January 1994, Biological trace element research,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
December 2023, Nutrients,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
March 2017, Biological trace element research,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
March 1991, Journal of surgical oncology,
J A Garofalo, and H Ashikari, and M L Lesser, and C Menendez-Botet, and S Cunningham-Rundles, and M K Schwartz, and R A Good
March 1998, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS),
Copied contents to your clipboard!